Treatment of Leptomeningeal Metastases in a Patient with Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
Conclusion: To our knowledge, this is the second reported case of LM in a patient with lung cancer harboring an EGFR T790M mutation that was successfully treated with osimertinib.Case Rep Oncol 2017;10:840 –845
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | MRI Scan | Neoplastic Meningitis | Neurology | Non-Small Cell Lung Cancer